-
ATP13A2 - Wikipedia Article Audio
For more information, please, visit: https://a.webull.com/KJLOK7GVRt9ngH7iql This is an audio version of a Wikipedia article created for the benefit of those who have vision problems or problem reading at night. This Wikipedia article audio was created under Creative Commons Attribution-ShareAlike. To view the original article, go to https://en.wikipedia.org/wiki/[AUDIO_TITLE].
published: 15 Jun 2018
-
Gene Music using Protein Sequence of ATP13A2 "ATPASE TYPE 13A2"
Shop ATP13A2 - https://www.redbubble.com/people/genemusic/works/55489006-atp13a2?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Gene Music Studio - A channel to taste (visually & musically) gene information (particularly protein sequences)
Gene Music using Protein Sequence of ATP13A2 'ATPASE TYPE 13A2'
published: 21 Apr 2017
-
A study by Benjamin Dehay and colleagues recently published in "PNAS"
Loss of ATP13A2/PARK9 induces general lysosomal deficiency: implications for Parkinson's disease.
published: 30 May 2012
-
4 4 35 Parkinsons Disease Clinical picture genetics 1207
published: 02 Dec 2013
-
The gene LRRK2 and its role in Parkinson's
Professor Dario Alessi from the University of Dundee, has developed a new way to measure the effect of mutations in LRRK2 – a gene linked to Parkinson's.
Watch Dario's lecture about the biology of Parkinson's https://youtu.be/JILd3P1mEuU
Doing my bit for Parkinson's research https://youtu.be/24SzeKFlx20
Subscribe for a new Parkinson's vid every week http://bit.ly/ParkinsonsUKYouTube
published: 19 Oct 2017
-
Picower Institute 20th Anniversary - Joel Blanchard
"Investigating Mechanisms of Aging with Stem Cells" by Joel Blanchard of Mt. Sinai. Blanchard spoke at The Picower Institute for Learning and Memory’s 20th Anniversary Exhibition. For more about The Picower Institute see: https://www.youtube.com/watch?v=BbEH3stKXZs and https://picower.mit.edu
published: 07 Oct 2022
-
Anthony Schapira: The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment...
Anthony Schapira (UCL, London, UK) expuso en el IV Congreso Internacional sobre Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) su ponencia “The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment in Parkinson disease”
La presentación del ponente la realizó José Ángel Obeso.
El congreso organizado por la Fundación Reina Sofía, la Fundación Centro de Investigación en Enfermedades Neurológicas (Fundación CIEN) y el Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), celebró su cuarta edición y, como en años anteriores reunió a más de un centenar de expertos nacionales e internacionales que analizaron los principales avances en el conocimiento y tratamiento de las enfermedades neurodegenerativas, fundamentalmente a...
published: 22 Sep 2016
-
Parkinsons Disease: A Neurodegenerative Disorder
Parkinson’s disease is a chronic degenerative disease which affects the brain, causing uncontrolled body movements like shaking, tremors and stiffness. It influences several motor and non-motor systems in the body. It is an age-related disorder, usually developing late at the age of 60 years, but sometimes it can occur in younger adults, particularly due to some environmental factors. It is the most commonly occurring movement-related or motor disease among all brain diseases. There are numerous factors that lead to the development of this disorder; however, the exact cause is still under debate. Inheriting mutated genes or any environmental factor like exposure to pesticides or certain chemicals or any head injury can eventually lead to Parkinson’s disease.
The brain is the command and co...
published: 22 Oct 2023
-
Understanding the biology behind Parkinson's
Disruptions to key biological processes in the body have been found to cause cancer and neurological problems. Professor Dario Alessi's research into this area attempts to understand the causes of Parkinson's.
Watch Dario's lecture about the LLRK2 gene https://youtu.be/PxminSb6tJU
Tai Chi and Parkinson's https://youtu.be/5JtRXMDlMT0
Subscribe for a new Parkinson's vid every week http://bit.ly/ParkinsonsUKYouTube
published: 16 Oct 2017
-
Gibco ExpressionWorld 2016: Structure and function of the Parkinson’s disease-associated protein LRR
Quyen Hoang, PhD discusses how he use Expi293 expression system to produce full-length LRRK2 for biochemical characterization and structural studies.
published: 28 Mar 2017
1:44
ATP13A2 - Wikipedia Article Audio
For more information, please, visit: https://a.webull.com/KJLOK7GVRt9ngH7iql This is an audio version of a Wikipedia article created for the benefit of those wh...
For more information, please, visit: https://a.webull.com/KJLOK7GVRt9ngH7iql This is an audio version of a Wikipedia article created for the benefit of those who have vision problems or problem reading at night. This Wikipedia article audio was created under Creative Commons Attribution-ShareAlike. To view the original article, go to https://en.wikipedia.org/wiki/[AUDIO_TITLE].
https://wn.com/Atp13A2_Wikipedia_Article_Audio
For more information, please, visit: https://a.webull.com/KJLOK7GVRt9ngH7iql This is an audio version of a Wikipedia article created for the benefit of those who have vision problems or problem reading at night. This Wikipedia article audio was created under Creative Commons Attribution-ShareAlike. To view the original article, go to https://en.wikipedia.org/wiki/[AUDIO_TITLE].
- published: 15 Jun 2018
- views: 26
2:30
Gene Music using Protein Sequence of ATP13A2 "ATPASE TYPE 13A2"
Shop ATP13A2 - https://www.redbubble.com/people/genemusic/works/55489006-atp13a2?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
...
Shop ATP13A2 - https://www.redbubble.com/people/genemusic/works/55489006-atp13a2?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Gene Music Studio - A channel to taste (visually & musically) gene information (particularly protein sequences)
Gene Music using Protein Sequence of ATP13A2 'ATPASE TYPE 13A2'
https://wn.com/Gene_Music_Using_Protein_Sequence_Of_Atp13A2_Atpase_Type_13A2
Shop ATP13A2 - https://www.redbubble.com/people/genemusic/works/55489006-atp13a2?asc=u
Subscribe - https://www.youtube.com/c/GeneMusicStudio?sub_confirmation=1
Gene Music Studio - A channel to taste (visually & musically) gene information (particularly protein sequences)
Gene Music using Protein Sequence of ATP13A2 'ATPASE TYPE 13A2'
- published: 21 Apr 2017
- views: 89
2:58
A study by Benjamin Dehay and colleagues recently published in "PNAS"
Loss of ATP13A2/PARK9 induces general lysosomal deficiency: implications for Parkinson's disease.
Loss of ATP13A2/PARK9 induces general lysosomal deficiency: implications for Parkinson's disease.
https://wn.com/A_Study_By_Benjamin_Dehay_And_Colleagues_Recently_Published_In_Pnas
Loss of ATP13A2/PARK9 induces general lysosomal deficiency: implications for Parkinson's disease.
- published: 30 May 2012
- views: 373
15:53
The gene LRRK2 and its role in Parkinson's
Professor Dario Alessi from the University of Dundee, has developed a new way to measure the effect of mutations in LRRK2 – a gene linked to Parkinson's.
Watch...
Professor Dario Alessi from the University of Dundee, has developed a new way to measure the effect of mutations in LRRK2 – a gene linked to Parkinson's.
Watch Dario's lecture about the biology of Parkinson's https://youtu.be/JILd3P1mEuU
Doing my bit for Parkinson's research https://youtu.be/24SzeKFlx20
Subscribe for a new Parkinson's vid every week http://bit.ly/ParkinsonsUKYouTube
https://wn.com/The_Gene_Lrrk2_And_Its_Role_In_Parkinson's
Professor Dario Alessi from the University of Dundee, has developed a new way to measure the effect of mutations in LRRK2 – a gene linked to Parkinson's.
Watch Dario's lecture about the biology of Parkinson's https://youtu.be/JILd3P1mEuU
Doing my bit for Parkinson's research https://youtu.be/24SzeKFlx20
Subscribe for a new Parkinson's vid every week http://bit.ly/ParkinsonsUKYouTube
- published: 19 Oct 2017
- views: 7409
21:45
Picower Institute 20th Anniversary - Joel Blanchard
"Investigating Mechanisms of Aging with Stem Cells" by Joel Blanchard of Mt. Sinai. Blanchard spoke at The Picower Institute for Learning and Memory’s 20th Ann...
"Investigating Mechanisms of Aging with Stem Cells" by Joel Blanchard of Mt. Sinai. Blanchard spoke at The Picower Institute for Learning and Memory’s 20th Anniversary Exhibition. For more about The Picower Institute see: https://www.youtube.com/watch?v=BbEH3stKXZs and https://picower.mit.edu
https://wn.com/Picower_Institute_20Th_Anniversary_Joel_Blanchard
"Investigating Mechanisms of Aging with Stem Cells" by Joel Blanchard of Mt. Sinai. Blanchard spoke at The Picower Institute for Learning and Memory’s 20th Anniversary Exhibition. For more about The Picower Institute see: https://www.youtube.com/watch?v=BbEH3stKXZs and https://picower.mit.edu
- published: 07 Oct 2022
- views: 128
44:44
Anthony Schapira: The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment...
Anthony Schapira (UCL, London, UK) expuso en el IV Congreso Internacional sobre Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) su ponenc...
Anthony Schapira (UCL, London, UK) expuso en el IV Congreso Internacional sobre Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) su ponencia “The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment in Parkinson disease”
La presentación del ponente la realizó José Ángel Obeso.
El congreso organizado por la Fundación Reina Sofía, la Fundación Centro de Investigación en Enfermedades Neurológicas (Fundación CIEN) y el Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), celebró su cuarta edición y, como en años anteriores reunió a más de un centenar de expertos nacionales e internacionales que analizaron los principales avances en el conocimiento y tratamiento de las enfermedades neurodegenerativas, fundamentalmente alzhéimer, párkinson y huntington.
El IV Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) se desarrolló los días 21, 22 y 23 de septiembre en la Oficina de Propiedad Intelectual de la Unión Europea (EUIPO) de Alicante.
https://wn.com/Anthony_Schapira_The_Glucocerebrosidase_Pathway_A_Paradigm_For_Pathogenesis_And_Treatment...
Anthony Schapira (UCL, London, UK) expuso en el IV Congreso Internacional sobre Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) su ponencia “The Glucocerebrosidase pathway: a paradigm for pathogenesis and treatment in Parkinson disease”
La presentación del ponente la realizó José Ángel Obeso.
El congreso organizado por la Fundación Reina Sofía, la Fundación Centro de Investigación en Enfermedades Neurológicas (Fundación CIEN) y el Centro de Investigación Biomédica en Red de Enfermedades Neurodegenerativas (CIBERNED), celebró su cuarta edición y, como en años anteriores reunió a más de un centenar de expertos nacionales e internacionales que analizaron los principales avances en el conocimiento y tratamiento de las enfermedades neurodegenerativas, fundamentalmente alzhéimer, párkinson y huntington.
El IV Congreso Internacional de Investigación e Innovación en Enfermedades Neurodegenerativas (CIIIEN) se desarrolló los días 21, 22 y 23 de septiembre en la Oficina de Propiedad Intelectual de la Unión Europea (EUIPO) de Alicante.
- published: 22 Sep 2016
- views: 1052
6:18
Parkinsons Disease: A Neurodegenerative Disorder
Parkinson’s disease is a chronic degenerative disease which affects the brain, causing uncontrolled body movements like shaking, tremors and stiffness. It influ...
Parkinson’s disease is a chronic degenerative disease which affects the brain, causing uncontrolled body movements like shaking, tremors and stiffness. It influences several motor and non-motor systems in the body. It is an age-related disorder, usually developing late at the age of 60 years, but sometimes it can occur in younger adults, particularly due to some environmental factors. It is the most commonly occurring movement-related or motor disease among all brain diseases. There are numerous factors that lead to the development of this disorder; however, the exact cause is still under debate. Inheriting mutated genes or any environmental factor like exposure to pesticides or certain chemicals or any head injury can eventually lead to Parkinson’s disease.
The brain is the command and control center for all the essential life processes and movements. Neurons or nerve cells are the basic functional units of the brain. Neurons are responsible for transmitting signals from the brain to muscle cells, glands and vice versa. Neurons communicate with each other and with other cells through specialized signaling molecules referred to as neurotransmitters. There are four major types of neurotransmitters, which include dopamine, serotonin, glutamate, and acetylcholine. According to studies, dopamine neurotransmitter and the Parkinson's disease have direct association and fluctuating levels of dopamine or absence of dopamine in the brain is the main reason for Parkinson’s disease.
There are motor-related and non-motor-related symptoms associated with Parkinson’s disease, including bradykinesia or decreased muscle control, unstable posture, frequent blinking, micrographia, drooling, dysphagia, hypophonia, hypotension or low blood pressure, frequent constipation, sexual dysfunctions, depression, anosmia, impaired sense of smell, dementia, and periodic limb movement disorder (PLMD). Common diagnostic methods to detect Parkinson's disease include computerized tomography (CT) scan, genetic testing, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, lumber puncture or spinal tap, and Skin biopsy. There are multiple medications and treatment options available for treating Parkinson’s disease. Increasing the already available dopamine is an effective approach to alleviating symptoms of Parkinson’s disease. This can be done by giving Levodopa to PD patients. Levodopa enhances dopamine levels and relieves many movement-related symptoms. Another approach is treating patients with dopamine agonists that stimulate the cells to act and behave like natural dopamine usually does to cells.
#parkinson
#parkinsonsawareness
#parkinsonsdiseasesupport
#parkinsonsexercise
#neurodegenerative
#neurodegenerativedisease
#dopamine
Follow us on Twitter, Facebook, Instagram, and TikTok
https://twitter.com/TheDiseaseBlog https://www.facebook.com/thediseaseblog
https://instagram.com/thediseaseblog
https://www.tiktok.com/@thediseasevlog
#periodiclimbmovementdisorder
#PLMD
#ctscan
#mriscan
#dementia
#bradykinesia
If you enjoyed this video, please to like, share, and subscribe to our channel for more captivating content. And as always, stay curious and keep exploring!
Follow us on Twitter, Facebook, Instagram, and TikTok
https://twitter.com/TheDiseaseBlog https://www.facebook.com/thediseaseblog
https://instagram.com/thediseaseblog
https://www.tiktok.com/@thediseasevlog
https://wn.com/Parkinsons_Disease_A_Neurodegenerative_Disorder
Parkinson’s disease is a chronic degenerative disease which affects the brain, causing uncontrolled body movements like shaking, tremors and stiffness. It influences several motor and non-motor systems in the body. It is an age-related disorder, usually developing late at the age of 60 years, but sometimes it can occur in younger adults, particularly due to some environmental factors. It is the most commonly occurring movement-related or motor disease among all brain diseases. There are numerous factors that lead to the development of this disorder; however, the exact cause is still under debate. Inheriting mutated genes or any environmental factor like exposure to pesticides or certain chemicals or any head injury can eventually lead to Parkinson’s disease.
The brain is the command and control center for all the essential life processes and movements. Neurons or nerve cells are the basic functional units of the brain. Neurons are responsible for transmitting signals from the brain to muscle cells, glands and vice versa. Neurons communicate with each other and with other cells through specialized signaling molecules referred to as neurotransmitters. There are four major types of neurotransmitters, which include dopamine, serotonin, glutamate, and acetylcholine. According to studies, dopamine neurotransmitter and the Parkinson's disease have direct association and fluctuating levels of dopamine or absence of dopamine in the brain is the main reason for Parkinson’s disease.
There are motor-related and non-motor-related symptoms associated with Parkinson’s disease, including bradykinesia or decreased muscle control, unstable posture, frequent blinking, micrographia, drooling, dysphagia, hypophonia, hypotension or low blood pressure, frequent constipation, sexual dysfunctions, depression, anosmia, impaired sense of smell, dementia, and periodic limb movement disorder (PLMD). Common diagnostic methods to detect Parkinson's disease include computerized tomography (CT) scan, genetic testing, magnetic resonance imaging (MRI), positron emission tomography (PET) scan, lumber puncture or spinal tap, and Skin biopsy. There are multiple medications and treatment options available for treating Parkinson’s disease. Increasing the already available dopamine is an effective approach to alleviating symptoms of Parkinson’s disease. This can be done by giving Levodopa to PD patients. Levodopa enhances dopamine levels and relieves many movement-related symptoms. Another approach is treating patients with dopamine agonists that stimulate the cells to act and behave like natural dopamine usually does to cells.
#parkinson
#parkinsonsawareness
#parkinsonsdiseasesupport
#parkinsonsexercise
#neurodegenerative
#neurodegenerativedisease
#dopamine
Follow us on Twitter, Facebook, Instagram, and TikTok
https://twitter.com/TheDiseaseBlog https://www.facebook.com/thediseaseblog
https://instagram.com/thediseaseblog
https://www.tiktok.com/@thediseasevlog
#periodiclimbmovementdisorder
#PLMD
#ctscan
#mriscan
#dementia
#bradykinesia
If you enjoyed this video, please to like, share, and subscribe to our channel for more captivating content. And as always, stay curious and keep exploring!
Follow us on Twitter, Facebook, Instagram, and TikTok
https://twitter.com/TheDiseaseBlog https://www.facebook.com/thediseaseblog
https://instagram.com/thediseaseblog
https://www.tiktok.com/@thediseasevlog
- published: 22 Oct 2023
- views: 116
11:09
Understanding the biology behind Parkinson's
Disruptions to key biological processes in the body have been found to cause cancer and neurological problems. Professor Dario Alessi's research into this area ...
Disruptions to key biological processes in the body have been found to cause cancer and neurological problems. Professor Dario Alessi's research into this area attempts to understand the causes of Parkinson's.
Watch Dario's lecture about the LLRK2 gene https://youtu.be/PxminSb6tJU
Tai Chi and Parkinson's https://youtu.be/5JtRXMDlMT0
Subscribe for a new Parkinson's vid every week http://bit.ly/ParkinsonsUKYouTube
https://wn.com/Understanding_The_Biology_Behind_Parkinson's
Disruptions to key biological processes in the body have been found to cause cancer and neurological problems. Professor Dario Alessi's research into this area attempts to understand the causes of Parkinson's.
Watch Dario's lecture about the LLRK2 gene https://youtu.be/PxminSb6tJU
Tai Chi and Parkinson's https://youtu.be/5JtRXMDlMT0
Subscribe for a new Parkinson's vid every week http://bit.ly/ParkinsonsUKYouTube
- published: 16 Oct 2017
- views: 1239
40:45
Gibco ExpressionWorld 2016: Structure and function of the Parkinson’s disease-associated protein LRR
Quyen Hoang, PhD discusses how he use Expi293 expression system to produce full-length LRRK2 for biochemical characterization and structural studies.
Quyen Hoang, PhD discusses how he use Expi293 expression system to produce full-length LRRK2 for biochemical characterization and structural studies.
https://wn.com/Gibco_Expressionworld_2016_Structure_And_Function_Of_The_Parkinson’S_Disease_Associated_Protein_Lrr
Quyen Hoang, PhD discusses how he use Expi293 expression system to produce full-length LRRK2 for biochemical characterization and structural studies.
- published: 28 Mar 2017
- views: 105